Macrocyclic quinazoline derivatives as antiproliferative agents

Details for Australian Patent Application No. 2004243487 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Willems, Marc; Schultz-Fademrecht, Carsten; Buijnsters, Peter Jacobus Johannes Antonius; Ten Holte, Peter; Perera, Timothy Pietro Suren; Embrechts, Werner Constant Johan; Freyne, Eddy Jean Edgard; Diels, Gaston Stanislas Marcella; Rombouts, Frederik Jan Rita

Agent Shelston IP

Pub. Number AU-B-2004243487

PCT Pub. Number WO2004/105765

Priority PCT/EP03/51061 18.12.03 EP; PCT/EP03/05723 27.05.03 EP; PCT/EP03/10266 15.09.03 EP

Filing date 25 May 2004

Wipo publication date 9 December 2004

Acceptance publication date 3 December 2009

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/529 (2006.01) - forming part of bridged ring systems

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/93 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2004/105765 Priority application(s): WO2004/105765

3 December 2009 Application Accepted

  Published as AU-B-2004243487

1 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243489-Drug delivery systems for tumor targeting NGR-molecules and uses thereof

2004243481-Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor